ReviewEuropean heart journal. Digital health2026
Artificial intelligence and the evolution of the electrocardiogram: from cardiovascular diagnostic tool to digital biomarker.
Review in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The electrocardiogram (ECG) is a cornerstone of cardiovascular care. Traditionally, it has relied on expert visual interpretation and rule-based systems to define the presence of disease. However, the integration of artificial intelligence (AI) has transformed the ECG into a high-dimensional biomarker capable of detecting signatures of both overt and subclinical disease. This review explores the historical progress of the technology from its inception to its diverse range of AI applications in the clinic and in research. We examine fundamental methodological advancements, including a range of deep learning methods, and the use of ECG images and wearable and portable devices for scaling these innovations globally. We also provide the full spectrum of AI-enabled care via applications for electrocardiograms, including (i) assistance to clinicians to perform interpretation of ECGs, (ii) augmenting their ability to detect latent signatures of disease from ECG, and (iii) prognostic and predictive applications of AI-ECG in cardiovascular care. Finally, we address critical challenges regarding model transparency, phenotypic selectivity, and the gap in the development of AI-ECG applications and their actual implementation. To realize the full potential of AI for ECGs, the field needs to evolve from singular AI-ECG tools evaluated in retrospective studies toward robust foundation models with broader multimodal integration and evaluation in rigorously performed randomized clinical trials. By unlocking latent physiological data, AI-ECG serves as a scalable engine for cardiovascular precision care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.